Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 4/20 | 0.59 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.46 |
| ▸ | DAO | P14920 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.33 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.33 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.33 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.33 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.33 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.33 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8816153 | 0.86 | CYP1A2 (0.65) | CYP1A2CYP2A6DAOALDH1A1CYP3A4 | |
| SCHEMBL7653968 | 0.83 | CYP1A2 (0.54) | CYP1A2CYP2A6DAOALDH1A1CYP3A4 | |
| SCHEMBL3078325 | 0.82 | CYP1A2 (0.59) | CYP1A2CYP2A6DAOALDH1A1CYP3A4 | |
| SCHEMBL7654607 | 0.79 | CYP1A2 (0.50) | CYP1A2CYP2A6DAOALDH1A1CYP3A4 | |
| SCHEMBL30975074 | 0.79 | CYP1A2 (0.62) | CYP1A2CYP2A6DAOALDH1A1CYP3A4 | |
| SCHEMBL9519292 | 0.79 | CYP1A2 (0.62) | CYP1A2CYP2A6DAOALDH1A1CYP3A4 | |
| SCHEMBL7754391 | 0.79 | CYP1A2 (0.62) | CYP1A2CYP2A6DAOALDH1A1CYP3A4 | |
| SCHEMBL10602531 | 0.78 | CYP1A2 (0.54) | CYP1A2CYP2A6CYP3A4CYP2C19CYP2D6 | |
| SCHEMBL7648088 | 0.78 | CYP1A2 (0.48) | CYP1A2CYP2A6DAOALDH1A1CYP3A4 | |
| SCHEMBL19676944 | 0.77 | CYP1A2 (0.59) | CYP1A2CYP2A6DAOALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1640430-B1 | Luminescent material and organic electroluminescent device using the same | JNC CORP (JP) | 2011-09-21 | — | — | EP | disclosed |
| EP-2177586-A1 | Luminescent material and organic electroluminescent device using the same | CHISSO CORPORATION (JP) | 2010-04-21 | — | — | EP | disclosed |
| EP-1640430-A1 | Luminescent material and organic electroluminescent device using the same | CHISSO CORPORATION (JP) | 2006-03-29 | — | — | EP | disclosed |
| US-20060014046-A1 | Luminescent material and organic electroluminescent device using the same | CHISSO CORPORATION (JP) | 2006-01-19 | — | — | US | disclosed |
| CN-1149214-C | Triazolo gerivatives and chemokine inhibitors containing the same as the active ingredient | ������������ʽ���� | 2004-05-12 | — | — | CN | disclosed |
| US-6492364-B1 | Triazolo and derivatives as chemokine inhibitors | TORAY INDUSTRIES, INC. (JP) | 2002-12-10 | — | — | US | disclosed |
| CN-1293674-A | Triazolo gerivatives and chemokine inhibitors containing the same as the active ingredient | TORAY INDUSTRIES (JP) | 2001-05-02 | — | — | CN | disclosed |
| EP-1067130-A1 | TRIAZOLO DERIVATIVES AND CHEMOKINE INHIBITORS CONTAINING THE SAME AS THE ACTIVE INGREDIENT | TORAY INDUSTRIES, INC. (JP) | 2001-01-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060014046-A1 | Luminescent material and organic electroluminescent device using the same | C1S, EPB41, EPB41L2 | CYP1A2 829/4885CYP2A6 1866/4885DAO 4223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.